摘要 |
The present invention relates to a pharmaceutical composition containing an FBPase inhibitor as an active ingredient, which is a preventative agent for diabetes mellitus, diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy, and the like and a therapeutic agent for IGT, and which can safely and easily be administered for a long period.
|